Abstract
Approximately 100 million people globally smoke cigarettes, making it a significant and quickly spreading global tobacco epidemic. Substance use disorders are frequently evaluated by non-randomized studies. Tobacco use and its impacts on the cardiovascular system were the subjects of a comprehensive search across five electronic databases: Cochrane, MEDLINE, Scopus, Embase, and PubMed. The findings demonstrated that waterpipe smokers in comparison to non-smokers have immediate elevations in heart rate and blood pressure, lower levels of high-density lipoprotein, higher levels of low-density lipoprotein, higher levels of triglycerides, higher levels of fasting blood glucose, and a higher heart rate. Users of waterpipes and cigarettes had similar average heart rates, blood pressure, and lipid levels, with the exception that waterpipe smokers had greater total cholesterol. Smoking a waterpipe has significant negative effects on the cardiovascular system comparable to cigarette smoking, and non-randomized studies proved to yield substantial evidence related to its cardiovascular effects. Such study designs can be used to evaluate substance use and its cardiovascular impact.
Keywords: cardiovascular disease, non-randomized studies, heated tobacco products, waterpipe, tobacco use disorder
Introduction and background
The main cause of mortality worldwide in 2015 was cardiovascular disease (CVD), which was responsible for 17.9 million deaths worldwide [1]. According to estimates, ventricular tachyarrhythmias account for roughly 80% of all sudden cardiac deaths, which account for around 40-50% of all cardiovascular (CV) deaths [2]. For instance, each year, between 250,000 and 310,000 sudden cardiac fatalities occur in the United States [3,4]. A cardiac arrhythmia is what causes sudden cardiac death, which is why the majority of cardiac arrests are fatal and usually occur without any prior warning signals [5-7]. The majority of sudden cardiac deaths occur in the general population and people without established coronary heart disease [8,9], despite the fact that preventive efforts have primarily focused on using cardioverter-defibrillators in the highest-risk groups, such as patients with advanced cardiomyopathy and reduced left ventricular ejection fraction [10]. Therefore, it stands to reason that population-wide primary preventive initiatives would be a more effective strategy to reduce sudden cardiac fatalities. Age, obesity, diabetes, inactivity, dietary variables, hypertension, high serum cholesterol, a high resting heart rate (HR), and a family history of sudden cardiac death are all recognized or suspected risk factors for sudden cardiac death [11,12]. A number of cohort studies have also found that smoking is strongly associated with an increased risk of sudden cardiac death; however, the intensity of the relationships observed has ranged from a 50% increase in risk to a 5.5-fold increase in risk [13-16]. The length of follow-up, geographic location, the definition of the reference group, discrepancies in sample numbers between studies, and/or chance fluctuation may all contribute to variations in effect sizes.
Waterpipe use has grown into a significant and quickly spreading global tobacco problem. The stylish feature of WPS (waterpipe smoking) and several other factors, particularly flavored smoke, have made it difficult to recognize the detrimental effects of WPS [17]. Furthermore, the water appears to remove the majority of hazardous chemicals from the smoke. The assumption made by users that the smoke is "filtered" by the water is false because a single WPS session lasts 30 to 90 minutes of nonstop smoking [18,19]. This prolonged period of time results in a large volume of smoke that contains up to 80 times more toxicants than those found in the smoke of a single cigarette and is carried through the water in the bubbles. It could be detrimental similar to cigarette smoking (CS). WPS may have negative CV effects, which have been observed in a number of dispersed research studies with varying findings based on various estimation methodologies. The total clinical impact of WPS on the CV system is not yet known. A few available studies on this topic had weak validity since they did not synthesize their data or were especially not concerned with CV outcomes [18,20-22]. To better understand the connection between WPS and CVD risk, we investigate the clinical CV effects of WPS statistically and qualitatively, compare them with those of tobacco smoking, and combine all relevant data from non-randomized studies.
Review
Methods
Study Design and Data Sources
In accordance with the guidelines and concepts outlined by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) framework, the current article is a systematic review and meta-analysis of case-control, cross-sectional, and non-randomized controlled trials [23]. We sought to identify and review the quality of literature pertaining to the topic in such studies. Five medical databases were thoroughly examined for admissible primary research pertinent to the topic at hand. To find English-language literature examining tobacco use and its effects on the CV system, searches were conducted in the following databases: Cochrane, Embase, MEDLINE, PubMed, and Scopus.
Search Strategy
This article’s keywords and key concepts were the focus of a detailed search strategy. The search procedure also included the Boolean expression, which mainly consisted of “AND” and “OR.” The terms “Tobacco smoking,” OR “Cigarette smoking,” OR “Waterpipe smoking,” AND “CVD,” OR “cardiovascular effects,” OR “cardiovascular disease” were utilized to the fullest extent possible. The search was restricted to research studies that were published in English.
Eligibility Criteria
The following inclusion criteria were applied to narrow down the pool of source articles for careful selection for analysis in this study: original articles, non-randomized studies, and English-language articles published between 2010 and 2022 examine the relationship between tobacco use and the risk of CVD.
On the other hand, studies were rejected and not taken into account based on the following criteria: secondary sources, such as journals, newspapers, and other academic research, studies that discuss the impacts of cigarette smoking and CVD, and studies that look at cigarette usage without considering the effects of CVD. Case studies and other study kinds were also discarded, as was the publication of main papers in languages other than English language, to prevent information loss and distortion through translation.
Data Extraction Quality Assessment
Two independent reviewers were in charge of choosing and extracting data from research that met the inclusion requirements for the PICO (Population, Intervention, Comparison, Outcome) framework [24]. Details on the authors, study methods, participant characteristics, intervention, comparison, and key findings or outcomes were among the factors that these reviewers acquired. A second reviewer was consulted to help with the harmonization and extraction of pertinent data for data and statistical analysis. This was done to address issues with data extraction. The Cochrane risk-of-bias tool was also utilized to assess the caliber of the study. This method uses six criteria, including reporting, blinding, selection, binding, attrition, and other biases, to categorize studies as having a low, high, or unknown risk of bias [25].
Statistical Analysis
It was effectively used to ensure that data analysis was conducted in accordance with the needs, and the data were gathered using the Cochrane Review Manager Software (RevMan version 5.4). According to the Cochrane criteria, each study utilized in a meta-analysis must have a consistent design and use comparable metrics. The mean difference (MD) and poled odds ratio were selected as the effect measures, each with a 95% level of confidence. The I-square (I2) test was employed to determine heterogeneity, with an I2 threshold of >50% signifying high heterogeneity and below 50% signifying low heterogeneity. The threshold for statistical significance was set at p<0.05 [26].
Results
Search Results
All 1,056 articles contained citations located in several databases besides searching through their reference lists. Only 16 of these non-randomized studies, all of which addressed the link between tobacco use and the risk of CVD, were found to meet the inclusion requirements and were pooled for analysis. The search strategy used to find the 16 articles pertinent to this inquiry is depicted in Figure 1. The number of studies not retrieved was 156 and, they were either paid access, no full text, or without valid website/journal links.
Study Characteristics
Table 1 describes the characteristics of the 16 included articles.
Table 1. Study characteristics.
Study | Study design | Participants | WPS | Intervention | Outcomes | |||||
N | Male | Age, mean (years) | Total | Frequency | Pre-session abstinence | Smoking settings | Smoking duration (min) | Tobacco used | ||
Blank et al. (2011) [27] | ES | 37 | 29 | 20.5 | 37 | ≤5 cigarettes per month | Overnight | Laboratory | 45 | 10 grams of tobacco |
Alomari et al. (2014) [28] | ES | 53 | 34 | 22.7 | 53 | ≥3 WPS per week | NS | Well-ventilated room | 30 | 10 grams |
Azar et al. (2016) [29] | ES | 194 | 112 | 35.6 | 101 | NS | 12 hours | Restaurants | 15 | NS |
Bentur et al. (2014) [30] | ES | 62 | 33 | 24.9 | 47 | NS | 24 hours | Indoor | 30 | 10 grams of moassal |
Al-Amri et al. (2019) [31] | CCS | 296 | 203 | 47.8 | 35 | Daily | NS | NS | - | - |
Chami et al. (2019) [32] | CCS | 345 | 233 | 53.7 | 175 | Daily | - | - | - | NS |
Ghasemi et al. (2010) [33] | CCS | 54 | 54 | 33.3 | 27 | Daily | NS | - | - | Frequently moassal |
Al Suwaidi et al. (2012) [34] | CSS | 7930 | 6253 | 59.6 | 130 | Regular | - | - | - | NS |
Khan et al. (2020) [35] | CSS | 73 | 41 | 39.8 | 12 | Daily | - | - | - | NS |
Platt et al. (2017) [36] | CSS | 7705 | 5188 | 61.2 | 574 | Regular | - | - | - | NS |
Nelson et al. (2016) [37] | ES | 28 | 20 | 27 | 28 | 12 times in the past year | 72 hours | Laboratory | 30 | NS |
Chwyeed (2018) [38] | CCS | 75 | 75 | 30 | 20 | NS | NS | - | - | NS |
Diab et al. (2015) [39] | CCS | 77 | 77 | 35.1 | 30 | Daily | NS | - | - | NS |
Rezk-Hanna and Benowitz (2019) [20] | ES | 55 | 10 | 26 | 40 | More than 12 times a year | Overnight | Laboratory | 40 | NS |
Saffar Soflaei et al. (2018) [40] | CSS | 9690 | NS | 35 | 1067 | NS | - | - | NS | NS |
Selim et al. (2013) [41] | CSS | 70 | 63 | 28.7 | 30 | Daily | NS | - | - | NS |
Risk-of-Bias Evaluation
Two researchers independently evaluated the risk of bias using the ROBINS-I (Risk Of Bias In Non-Randomized Studies - of Interventions) instrument, as depicted in Figure 2, which the Cochrane Bias Methods Group recommends for evaluating the risk of bias in non-randomized interventions [42]. A third investigator was consulted in the event of differences.
Acute Effects of Tobacco Smoking
A meta-analysis was conducted for each of the three measures, HR, systolic blood pressure (SBP), and diastolic blood pressure (DBP), to determine the acute impact of WPS on each. The findings demonstrated that a single WPS session resulted in acute increases in mean HR (MD: 10.57; 95% CI: 7.63 to 13.51; I2 = 96%), SBP (MD: 5.19; 95% CI: 2.04 to 8.35; I2 = 95%), and DBP (MD: 4.88; 95% CI: 2.46 to 7.30; I2 = 84%). The acute effect of WPS on these three hemodynamic measures remained significant even when statistical heterogeneity in the sensitivity analysis was eliminated (Figure 3).
Non-Acute Effects
According to the findings, waterpipe smokers tend to have greater blood pressure (BP) than non-smokers, with a mean HR that is higher (MD: 0.82; 95% CI: -1.23 to 2.86; I2 = 47%). Once the statistical heterogeneity from the sensitivity studies was considered, there was no significant correlation between WPS and any of these hemodynamic measures. The overall pooled effect was insignificant (MD: 0.28; 95% CI: -1.26 to 1.83; I2 = 83%) (Figure 4).
Lipoproteins
By performing the meta-analysis for each of TC (total cholesterol), LDL (low-density lipoprotein), HDL (high-density lipoprotein) cholesterol, and TG (triglycerides), and having dyslipidemia, it was possible to determine whether WPS and serum lipid levels are correlated. The results showed that when compared to non-smokers, waterpipe smokers had lower mean HDL cholesterol (MD: -3.87; 95% CI: -6.06 to -1.68), higher mean TG (MD: 47.63; 95% CI: 3.66 to 91.59), and higher mean LDL cholesterol (MD: 0.76; 95% CI: -0.99 to 2.51; I2 = 0%). Even after statistical heterogeneity in the sensitivity analysis was eliminated, there was still a significant connection between WPS and higher TG levels and lower HDL cholesterol (Figure 5).
Data from three trials were combined, and the results showed that waterpipe users had greater mean TC than cigarette smokers (MD: 2.89; 95% CI: -0.16 to 5.93; I2 = 90%). No differences were discovered in terms of TG, dyslipidemia, LDL, HDL, or TG values. However, reducing the statistical heterogeneity in sensitivity analysis indicated a strong association between WPS and TG levels (Figure 6).
Cardiovascular Effects
A meta-analysis revealed no HR, SBP, or DBP changes between waterpipe and cigarette smokers. Sensitivity analyses revealed significantly higher mean HRs (MD: 0.87; 95% CI: -3.09 to 4.84; I2 = 91%), SBPs (MD: 1.78; 95% CI: -1.13 to 4.68; I2 = 72%), and DBPs (MD: 0.40; 95% CI: -2.41 to 3.20; I2 = 82%) after statistical heterogeneity was removed (Figure 7).
Discussion
Increased HR and BP, the two most common hemodynamic parameters used to evaluate the CV system, are known to have a deleterious impact on CV outcomes [43,44]. Our findings show that a single WPS session significantly raises HR, SBP, and DBP. This alone could increase the heart's need for oxygen, increase blood vessel shear stress, and occasionally trigger ACS (acute coronary syndrome), raising morbidity and death. It is reasonable to assume that the accumulation of these acute adverse effects will have a negative long-term impact on prognosis because waterpipe is typically consumed regularly several times a week. Our findings, however, indicate that while SBD and DBP tend to be higher among waterpipe smokers, they do not statistically differ from those who do not smoke in terms of HR from non-smokers. These results are somewhat unexpectedly different from those seen with WPS's acute effects, which could be partially explained by the studies' significant heterogeneity. Additionally, years of smoking and the frequency and length of WPS sessions were not controlled between trials, which could have an impact on the findings. The frequency of weekly waterpipe use was previously found to be significantly positively correlated with SBP, SBP, and HR [45]. The nicotine exposure that raises the sympathetic nervous system's activity and causes an increase in HR, myocardial contractility, and cardiac output may be partially responsible for the acute hemodynamic abnormalities identified in our findings [46]. Three trials contrasting flavor-matched tobacco with tobacco-free WPS have revealed such an effect [27,47,48]. However, regardless of nicotine concentration, an immediate cardiac autonomic dysregulation was seen after a WPS session.
Additionally, due to the creation of carboxy-hemoglobin (CO-Hb), the high exposure levels to CO (carbon monoxide) during WPS may result in a reduction in the amount of oxygen delivered to tissues, including the heart. Furthermore, it is well known that hypoxia is a powerful stimulator of a number of autonomic processes, increasing resting HR, BP, and cardiac output. These results counter the damage reduction claims of purportedly "herbal" waterpipe products and are consistent with non-clinical research employing a waterpipe machine that mimics a human being [49]. Due to a lack of data from long-term trials, it is impossible to say how much WPS may be long-term hemodynamically damaging.
A strong association of WPS with elevated TG, LDL cholesterol, and lower HDL cholesterol levels, all known to be CVD risk factors that encourage atherosclerosis, was found when data from the available studies were combined. As is common knowledge for CS, the underlying mechanisms are not entirely understood. However, it has recently been proposed that TG/HDL imbalances are linked to insulin resistance [50]. Our findings, which demonstrated a significantly higher FBG (fasting blood glucose) in waterpipe smokers compared to non-smokers, are consistent with this. It has been previously documented that CS increases coagulation factors' activity and the risk of thrombosis [51].
Similarly, WPS is associated with higher fibrinogen levels, which may increase thrombogenicity and raise the risk of CV events [35]. Clinical evidence for the probable involvement of WPS in vascular disease can be seen in the elevated CAC (coronary artery calcium) score, and the acute and chronic endothelial dysfunction found among waterpipe smokers [20,28,32,39,41]. Our research on the impact of WPS on the CV system explains and supports findings from studies that found a connection between WPS and CVD incidence, poorer clinical outcomes, and projected prognoses [34,36,41].
The comparison between WPS and CS is crucial because the CV effects of CS are well-known [50]. Unfortunately, there were fewer articles available for this comparison. The main drawback may be the dearth of studies comparing the incidence of CV and cerebrovascular events in waterpipe smokers to those of cigarette smokers. Our findings, however, suggest that the non-acute effects of WPS on the great majority of relevant CV measures are comparable to those brought about by CS. The limited studies did not clearly distinguish between WPS and CS regarding CVD incidence [34,40]. Additionally, compared to cigarette smokers, waterpipe smokers have a higher incidence of CVD complications and mortality [34]. This could be attributed to prolonged WPS, which would result in greater levels of hazardous chemicals breathed and detrimental consequences on the CV system [52]. Our analysis had similar results to a meta-analysis that studied randomized studies as well [53]. Although ours had non-randomized studies, it still proved to be useful in formulating evidence regarding the CV impact of tobacco use. There are several reasons why non-randomized studies, such as observational and cohort studies, can be useful in addition to randomized controlled trials (RCTs) in studying the effects of tobacco use and WPS on CV health. Non-randomized studies can provide valuable information on the patterns of exposure and outcome in real-world populations, which may be different from those in RCTs. This can increase the generalizability of findings to the general population. Non-randomized studies can be useful in assessing the long-term effects of exposure over time, which may not be captured in RCTs that are usually shorter. These types of studies can be useful in identifying populations that may be at particularly high risk of harm from tobacco use and WPS, which can help inform public health interventions. Non-randomized studies can be less expensive and more feasible to conduct than RCTs, which can be logistically and financially challenging [54]. Furthermore, they can be useful in identifying potential mechanisms of harm, which can inform future research and intervention development. Lastly, such studies can generate hypotheses for further investigation in RCTs. It is important to note that both randomized and non-randomized studies have their own limitations and strengths. While RCTs can provide the highest level of evidence for causality, non-randomized studies can provide important information on real-world patterns of exposure and outcomes and can complement the findings from RCTs [54].
On the other hand, the long-term effects of WPS should be considered, as a recent mouse model that revealed cessation of smoking relieves waterpipe smoke-induced hypercoagulability and cardiac injury [55]. It is possible the CV effects resolve in most of the patients with cessation of WPS. Considering the other long-term complications, such as an increase in the incidence of cancer and death attributable to WPS, highlights the pressing need to encourage smoking cessation [56].
Limitations
The comparison of WPS and CS may be the most significant aspect of the review; however, there are not many studies that can be used for this comparison, and the absence of research that reflects the frequency of CV and cerebrovascular events is the biggest drawback. However, some waterpipe users might have previously smoked cigarettes. The amount of time spent smoking cigarettes likely influences the results. Most studies miss this information. As a result, it is impossible to do a meta-regression that takes the period since CS cessation in waterpipe smokers. This is relevant to the other findings that revealed waterpipe users to have a worse cardiometabolic profile than non-smokers, as many studies did not account for all potential confounders when comparing.
Conclusions
The prevalent misconception that WPS is safe and does not involve smoking still exists. The variety of WPS's short- and long-term CV effects are described in this article. Despite the aforementioned restrictions, the degree of evidence implies that WPS is linked to significant negative effects on the CV system, which resemble those documented for CS. In particular, non-randomized studies are a helpful tool where randomized studies are difficult and still yield results that although may have some bias but enough to draw useful and similar conclusions to randomized trials.
Acknowledgments
Kamran Mahfooz and Advait Vasavada contributed equally to the work and should be considered co-first authors. Individual Contribution: Kamran Mahfooz and Advait Vasavada: Conceptualization, data extraction, screening of literature, writing - original draft, and project administration. Arpit Joshi, Srikrishnan Pichuthirumalai, and Rupesh Andani: Conceptualization, retrieval of studies and raw data, data extraction, writing - original draft. Arush Rajotia, Aakash Hans, Bilvesh Mandalia, Neeraj Dayama, Zara Younas, and Nosheen Hafeez: Conceptualization, analysis, writing - original draft. Niharika Bheemisetty, Yash Patel, Hemalatha Tumkur Ranganathan, and Ashok Sodala: Conceptualization, verifying search strategy and analysis independently, writing - original draft, reviewing and copyediting drafts.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
Footnotes
The authors have declared that no competing interests exist.
References
- 1.Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Wang H, Naghavi M, Allen C, et al. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Global public health problem of sudden cardiac death. Mehra R. J Electrocardiol. 2007;40:0–22. doi: 10.1016/j.jelectrocard.2007.06.023. [DOI] [PubMed] [Google Scholar]
- 3.Epidemiology of sudden cardiac death: clinical and research implications. Chugh SS, Reinier K, Teodorescu C, et al. Prog Cardiovasc Dis. 2008;51:213–228. doi: 10.1016/j.pcad.2008.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Tsao CW, Aday AW, Almarzooq ZI, et al. Circulation. 2022;145:0–639. doi: 10.1161/CIR.0000000000001052. [DOI] [PubMed] [Google Scholar]
- 5.Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Fishman GI, Chugh SS, Dimarco JP, et al. Circulation. 2010;122:2335–2348. doi: 10.1161/CIRCULATIONAHA.110.976092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Epidemiology and genetics of sudden cardiac death. Deo R, Albert CM. Circulation. 2012;125:620–637. doi: 10.1161/CIRCULATIONAHA.111.023838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Regional variation in out-of-hospital cardiac arrest incidence and outcome. Nichol G, Thomas E, Callaway CW, et al. JAMA. 2008;300:1423–1431. doi: 10.1001/jama.300.12.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Prospective study of sudden cardiac death among women in the United States. Albert CM, Chae CU, Grodstein F, et al. Circulation. 2003;107:2096–2101. doi: 10.1161/01.CIR.0000065223.21530.11. [DOI] [PubMed] [Google Scholar]
- 9.Out-of-hospital cardiac arrest in the 1990’s: a population-based study in the Maastricht area on incidence, characteristics and survival. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, van Ree JW, Daemen MJ, Houben LG, Wellens HJ. J Am Coll Cardiol. 1997;15:1500–1505. doi: 10.1016/s0735-1097(97)00355-0. [DOI] [PubMed] [Google Scholar]
- 10.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. Moss AJ, Zareba W, Hall WJ, et al. N Engl J Med. 2002;346:877–883. doi: 10.1056/NEJMoa013474. [DOI] [PubMed] [Google Scholar]
- 11.Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies. Aune D, Sen A, ó'Hartaigh B, Janszky I, Romundstad PR, Tonstad S, Vatten LJ. Nutr Metab Cardiovasc Dis. 2017;27:504–517. doi: 10.1016/j.numecd.2017.04.004. [DOI] [PubMed] [Google Scholar]
- 12.Predicting sudden death in the population: the Paris Prospective Study I. Jouven X, Desnos M, Guerot C, Ducimetière P. Circulation. 1999;99:1978–1983. doi: 10.1161/01.cir.99.15.1978. [DOI] [PubMed] [Google Scholar]
- 13.Risk factors for sudden cardiac death in middle-aged British men. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Circulation. 1995;91:1749–1756. doi: 10.1161/01.cir.91.6.1749. [DOI] [PubMed] [Google Scholar]
- 14.The mortality risks of smokers in Taiwan: Part I: cause-specific mortality. Wen CP, Tsai SP, Chen CJ, Cheng TY. Prev Med. 2004;39:528–535. doi: 10.1016/j.ypmed.2004.02.010. [DOI] [PubMed] [Google Scholar]
- 15.The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. J Intern Med. 2007;262:360–367. doi: 10.1111/j.1365-2796.2007.01813.x. [DOI] [PubMed] [Google Scholar]
- 16.Serum β-carotene and the risk of sudden cardiac death in men: a population-based follow-up study. Karppi J, Laukkanen JA, Mäkikallio TH, Ronkainen K, Kurl S. Atherosclerosis. 2013;226:172–177. doi: 10.1016/j.atherosclerosis.2012.10.077. [DOI] [PubMed] [Google Scholar]
- 17.The global epidemiology of waterpipe smoking. Maziak W, Taleb ZB, Bahelah R, Islam F, Jaber R, Auf R, Salloum RG. Tob Control. 2015;24 Suppl 1:0. doi: 10.1136/tobaccocontrol-2014-051903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Health effects associated with waterpipe smoking. El-Zaatari ZM, Chami HA, Zaatari GS. Tob Control. 2015;24 Suppl 1:0–43. doi: 10.1136/tobaccocontrol-2014-051908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Investigation of mainstream smoke aerosol of the argileh water pipe. Shihadeh A. Food Chem Toxicol. 2002;41:143–152. doi: 10.1016/s0278-6915(02)00220-x. [DOI] [PubMed] [Google Scholar]
- 20.Cardiovascular effects of hookah smoking: potential implications for cardiovascular risk. Rezk-Hanna M, Benowitz NL. Nicotine Tob Res. 2019;21:1151–1161. doi: 10.1093/ntr/nty065. [DOI] [PubMed] [Google Scholar]
- 21.Cardiopulmonary risk of waterpipe smoke: a meta-analysis. Marshall MR, Ghazipura M, Hossain T, Gordon T, Chen LC. J Lung Health Dis. 2018;2:31–40. [Google Scholar]
- 22.The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis. Waziry R, Jawad M, Ballout RA, Al Akel M, Akl EA. Int J Epidemiol. 2017;46:32–43. doi: 10.1093/ije/dyw021. [DOI] [PubMed] [Google Scholar]
- 23.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Moher D, Shamseer L, Clarke M, et al. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Amir-Behghadami M, Janati A. Emerg Med J. 2020;37:387. doi: 10.1136/emermed-2020-209567. [DOI] [PubMed] [Google Scholar]
- 25.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Higgins JP, Altman DG, Gøtzsche PC, et al. BMJ. 2011;343:0. doi: 10.1136/bmj.d5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: John Wiley & Sons; 2019. Cochrane Handbook for Systematic Reviews of Interventions. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study. Blank MD, Cobb CO, Kilgalen B, Austin J, Weaver MF, Shihadeh A, Eissenberg T. Drug Alcohol Depend. 2011;116:102–109. doi: 10.1016/j.drugalcdep.2010.11.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Central and peripheral cardiovascular changes immediately after waterpipe smoking. Alomari MA, Khabour OF, Alzoubi KH, Shqair DM, Eissenberg T. Inhal Toxicol. 2014;26:579–587. doi: 10.3109/08958378.2014.936572. [DOI] [PubMed] [Google Scholar]
- 29.Acute effects of waterpipe smoking on blood pressure and heart rate: a real-life trial. Azar RR, Frangieh AH, Mroué J, Bassila L, Kasty M, Hage G, Kadri Z. Inhal Toxicol. 2016;28:339–342. doi: 10.3109/08958378.2016.1171934. [DOI] [PubMed] [Google Scholar]
- 30.Laboratory and clinical acute effects of active and passive indoor group water-pipe (narghile) smoking. Bentur L, Hellou E, Goldbart A, et al. Chest. 2014;145:803–809. doi: 10.1378/chest.13-0960. [DOI] [PubMed] [Google Scholar]
- 31.Waterpipe smoking and the risk of myocardial infarction: a hospital-based case-control study. Al-Amri A, Ghalilah K, Al-Harbi A, Al-Dubai SA, Al-Ghamdi S, Al-Zalabani A. Tob Induc Dis. 2019;17:87. doi: 10.18332/tid/114074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.The association of water-pipe smoking and coronary artery calcium in a community-based sample. Chami HA, Isma'eel H, Tamim H, Adawi M, Al Kuwari M, Al Mullah A. Chest. 2019;155:1217–1225. doi: 10.1016/j.chest.2019.01.010. [DOI] [PubMed] [Google Scholar]
- 33.The influence of cigarette and qalyan (hookah) smoking on serum nitric oxide metabolite concentration. Ghasemi A, Syedmoradi L, Momenan AA, Zahediasl S, Azizi F. Scand J Clin Lab Invest. 2010;70:116–121. doi: 10.3109/00365511003611282. [DOI] [PubMed] [Google Scholar]
- 34.Tobacco modalities used and outcome in patients with acute coronary syndrome: an observational report. Al Suwaidi J, Al Habib K, Singh R, et al. Postgrad Med J. 2012;88:566–574. doi: 10.1136/postgradmedj-2011-130178. [DOI] [PubMed] [Google Scholar]
- 35.Systemic biomarkers of inflammation, oxidative stress and tissue injury and repair among waterpipe, cigarette and dual tobacco smokers. Khan NA, Lawyer G, McDonough S, et al. Tob Control. 2020;29:0–9. doi: 10.1136/tobaccocontrol-2019-054958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Association of waterpipe smoking with myocardial infarction and determinants of metabolic syndrome among catheterized patients. Platt DE, Hariri E, Salameh P, et al. Inhal Toxicol. 2017;29:429–434. doi: 10.1080/08958378.2017.1384085. [DOI] [PubMed] [Google Scholar]
- 37.Acute effect of hookah smoking on the human coronary microcirculation. Nelson MD, Rezk-Hanna M, Rader F, et al. Am J Cardiol. 2016;117:1747–1754. doi: 10.1016/j.amjcard.2016.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.A comparison between the effect of shisha and cigarette smoking on serum lipid profile of males in Nasiriyah City. Chwyeed SH. Med J Babylon. 2018;15:39. [Google Scholar]
- 39.Effect of water pipe tobacco smoking on plasma high sensitivity C reactive protein level and endothelial function compared to cigarette smoking. Diab OA, Abdelrahim EM, Esmail M. Egypt Heart J. 2015;67:233–241. [Google Scholar]
- 40.Hookah smoking is strongly associated with diabetes mellitus, metabolic syndrome and obesity: a population-based study. Saffar Soflaei S, Darroudi S, Tayefi M, et al. Diabetol Metab Syndr. 2018;10:33. doi: 10.1186/s13098-018-0335-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Impact of shisha smoking on the extent of coronary artery disease in patients referred for coronary angiography. Selim GM, Fouad H, Ezzat S. https://pubmed.ncbi.nlm.nih.gov/23996801/ Anadolu Kardiyol Derg. 2013;13:647–654. doi: 10.5152/akd.2013.191. [DOI] [PubMed] [Google Scholar]
- 42.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Sterne JA, Hernán MA, Reeves BC, et al. BMJ. 2016;355:0. doi: 10.1136/bmj.i4919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Ettehad D, Emdin CA, Kiran A, et al. Lancet. 2016;387:957–967. doi: 10.1016/S0140-6736(15)01225-8. [DOI] [PubMed] [Google Scholar]
- 44.Heart rate and its reduction in chronic heart failure and beyond. Nikolovska Vukadinović A, Vukadinović D, Borer J, et al. Eur J Heart Fail. 2017;19:1230–1241. doi: 10.1002/ejhf.902. [DOI] [PubMed] [Google Scholar]
- 45.Does shisha smoking affect blood pressure and heart rate? Al-Safi SA, Ayoub NM, Albalas MA, Al-Doghim I, Aboul-Enein FH. J Public Health. 2009;17:121–126. [Google Scholar]
- 46.Pathophysiological mechanisms of tobacco-related CVD. Salahuddin S, Prabhakaran D, Roy A. Glob Heart. 2012;7:113–120. doi: 10.1016/j.gheart.2012.05.003. [DOI] [PubMed] [Google Scholar]
- 47.Acute toxicant exposure and cardiac autonomic dysfunction from smoking a single narghile waterpipe with tobacco and with a "healthy" tobacco-free alternative. Cobb CO, Sahmarani K, Eissenberg T, Shihadeh A. Toxicol Lett. 2012;215:70–75. doi: 10.1016/j.toxlet.2012.09.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Young adult waterpipe smokers: Smoking behaviors and associated subjective and physiological effects. Shishani K, Howell D, McPherson S, Roll J. Addict Behav. 2014;39:1113–1119. doi: 10.1016/j.addbeh.2014.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.'Herbal' but potentially hazardous: an analysis of the constituents and smoke emissions of tobacco-free waterpipe products and the air quality in the cafés where they are served. Hammal F, Chappell A, Wild TC, et al. Tob Control. 2015;24:290–297. doi: 10.1136/tobaccocontrol-2013-051169. [DOI] [PubMed] [Google Scholar]
- 50.The pathophysiology of cigarette smoking and cardiovascular disease: an update. Ambrose JA, Barua RS. J Am Coll Cardiol. 2004;43:1731–1737. doi: 10.1016/j.jacc.2003.12.047. [DOI] [PubMed] [Google Scholar]
- 51.Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study. Eliasson M, Asplund K, Evrin PE, Lundblad D. Atherosclerosis. 1995;113:41–53. doi: 10.1016/0021-9150(94)05425-i. [DOI] [PubMed] [Google Scholar]
- 52.Lifetime cumulative exposure to waterpipe smoking is associated with coronary artery disease. Sibai AM, Tohme RA, Almedawar MM, Itani T, Yassine SI, Nohra EA, Isma'eel HA. Atherosclerosis. 2014;234:454–460. doi: 10.1016/j.atherosclerosis.2014.03.036. [DOI] [PubMed] [Google Scholar]
- 53.Cardiovascular effects of waterpipe smoking: a systematic review and meta-analysis. Al Ali R, Vukadinović D, Maziak W, et al. https://doi.org/10.31083/j.rcm.2020.03.135. Rev Cardiovasc Med. 2020;21:453–468. doi: 10.31083/j.rcm.2020.03.135. [DOI] [PubMed] [Google Scholar]
- 54.Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making. Sarri G, Patorno E, Yuan H, et al. BMJ Evid Based Med. 2022;27:109–119. doi: 10.1136/bmjebm-2020-111493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Waterpipe smoke-induced hypercoagulability and cardiac injury in mice: influence of cessation of exposure. Nemmar A, Al-Salam S, Beegam S, Zaaba NE, Elzaki O, Yasin J, Ali BH. Biomed Pharmacother. 2022;146:112493. doi: 10.1016/j.biopha.2021.112493. [DOI] [PubMed] [Google Scholar]
- 56.National and regional fraction of cancer incidence and death attributable to current tobacco and water-pipe smoking in the eastern Mediterranean countries in 2020. Nemati S, Naji P, Abdi S, et al. Nicotine Tob Res. 2023;25:12–18. doi: 10.1093/ntr/ntac179. [DOI] [PubMed] [Google Scholar]